One year of COVID-19: infection rates and symptoms in patients with inherited metabolic diseases followed by MetabERN.

Laura PaneghettiCinzia Maria BellettatoAnnalisa SechiKarolina M StepienMaurizio Scarpa

Published in: Orphanet journal of rare diseases (2022)

Most of MetabERN's IMD patients who got COVID-19 during the first year of the pandemic had mild symptoms and a positive outcome of the disease. However, fatal events were recorded in paediatric patients; this, together with the lack of information on the long-term effects of COVID-19 in IMDs, call for caution in the metabolic population.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
emergency department
prognostic factors
respiratory syndrome coronavirus
healthcare
patient reported outcomes
depressive symptoms